Melanoma-associated antigen 9B (MAGEA9B)

Melanoma-associated antigen 9B (MAGEA9B) is a protein-coding gene that is a paralog and duplication of the canonical MAGEA9 gene. It belongs to the MAGE (melanoma antigen) family, which is characterized primarily as cancer/testis antigens with restricted expression in adult somatic tissues except for the testis and various cancers. Although MAGEA9B shares sequence similarities with other MAGEA genes that regulate cellular processes such as apoptosis, survival, and ubiquitination by interacting with E3 ubiquitin ligases, specific functional data for MAGEA9B are lacking. MAGE family proteins have been implicated in driving tumorigenesis and predicting poor prognosis in a variety of cancers. There is genetic linkage to rare hereditary disorders such as terminal osseous dysplasia. Therapeutic targeting is largely conceptual based on family resemblance; no drugs specifically interact with MAGEA9B, but related CT antigens are under investigation as cancer immunotherapeutic targets[1][2][3][4][5].

Other names

MAGE family member A9BMAGEA9BMelanoma-associated antigen 9BMAGEA9MAGE9MAGEA9ACT1.9Cancer/testis antigen 1.9MAGE-9 antigenmelanoma antigen family A, 9B

For cancer/testis antigens (CTAs) like MAGEA9B, potential mechanism involves immunotherapy approaches targeting the antigen (e.g., cancer vaccines), but no specific drugs or mechanisms are described for MAGEA9B[1][3].